TrialJAMA network open2024

Abatacept Pharmacokinetics and Exposure Response in Patients Hospitalized With COVID-19: A Secondary Analysis of the ACTIV-1 IM Randomized Clinical Trial.

Stephen J Balevic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.